Humana Inc.
HUMNYSEHealthcareHealthcare Plans
As of Oct 22, 2026 close
- Market cap
- $50.99B
- P/E (TTM)
- 39.87
- Forward P/E
- 48.96
- Dividend yield
- 0.63%
- 52-week range
- $163.11$456.50
- Volume (live)
- -
- Avg. volume (3M)
- 1.42M
Humana (HUM) Stock Price & Financial Analysis
Humana Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $417.49 - $428.31 |
|---|---|
| 52-Week High | $456.50 |
| 52-Week Low | $163.11 |
| Open | $423.16 |
| Volume (last close) | 1.81M |
| Average Volume (3M) | 1.42M |
| Revenue (TTM) | 145.68B |
|---|---|
| Net Income (TTM) | 1.28B |
| Free Cash Flow (TTM) | 1.95B |
| EPS (TTM) | $10.60 |
| Profit Margin | 0.88% |
| Operating Margin | 1.71% |
| Return on Equity (ROE) | 6.63% |
| Debt to Equity | 0.74 |
| Annual Dividend | $2.66 |
|---|---|
| Dividend Yield | 0.63% |
| Payout Ratio | 25.06% |
| Next Dividend Ex-Date | Oct 30, 2026 |
| Market Cap | 50.99B |
|---|---|
| Shares Outstanding | 121.14M |
| P/E Ratio (TTM) | 39.87 |
| Forward P/E | 48.96 |
| Price to Sales (P/S) | 0.35 |
| Price to Book (P/B) | 2.65 |
| EV/EBITDA | 15.21 |
| 50-Day MA | $395.35 |
|---|---|
| 200-Day MA | $302.67 |
| 1-Year Change | +44.51% |
Source: Market prices and company fundamentals. Data as of Oct 22, 2026. Data sources and methodology
Humana at a Glance
As of the Oct 22, 2026 close, Humana (HUM) has a market capitalization of $50.99B. The stock trades at 39.9× trailing earnings, 49.0× forward earnings and 0.3× sales. Over the trailing twelve months it earned $1.28B on revenue of $145.68B (a 0.9% profit margin) and generated $1.95B of free cash flow. Revenue grew 18.3% year over year.
As of its latest reported balance sheet, it holds $6.89B in cash and securities against $14.25B of debt, a net debt position of $7.35B.
Humana pays a quarterly dividend totaling $2.65 per share a year, a 0.63% yield at the Oct 22, 2026 close, with a 25% payout ratio.
The share price is up 44.5% over the past year. At $420.97 (the Oct 22, 2026 close) it sits near the top of its 52-week range of $163.11 to $456.50, above its 200-day moving average of $302.67.
Based on 29 professional analyst ratings from the past 90 days, the consensus is Buy with an average price target of $457.32, 8.6% above the Oct 22, 2026 close.
Frequently Asked Questions About Humana
What is the current stock price for HUM?
As of the Oct 22, 2026 close, HUM stock trades at $420.97. The 52-week range is $163.11–$456.50, with a day range of $417.49–$428.31.
What is the P/E ratio for HUM?
As of the Oct 22, 2026 close, Humana's trailing twelve-month (TTM) P/E ratio is 39.9, meaning investors pay $39.9 for every $1 of annual earnings. The forward P/E is 49.0, reflecting analyst expectations for future earnings. Humana operates in the Healthcare sector.
Does HUM pay dividends?
Yes, Humana pays a 0.63% annual dividend yield as of the Oct 22, 2026 close ($2.65 per share a year). The trailing twelve-month payout ratio is 25.1%. The next ex-dividend date is October 30, 2026.
What do analysts recommend for HUM?
Based on ratings from 29 professional analysts over the last 90 days, the consensus for HUM is Buy. The average 12-month price target is $457.32, a 8.6% upside from the Oct 22, 2026 close of $420.97.
What is the market cap of HUM?
As of the Oct 22, 2026 close, Humana's market capitalization is $50.99B, classifying it as a large-cap company. Humana operates in the Healthcare sector within the Healthcare Plans industry.